Position in MRK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,263,527
+$114,547 QoQ
Shares Held
17,615
-1.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#1,510
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WHALEROCK POINT PARTNERS, LLC holds $17,592,227 across 8 Drug Manufacturers - General names. MRK ranks #4 (12.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
30,416 | $7,724,751 | |
| 2 | LLY |
ELI LILLY & Co
|
2,589 | $3,105,324 | |
| 3 | ABBV |
AbbVie Inc.
|
10,057 | $2,530,743 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
17,615 | $2,263,527 | |
| 5 | PFE |
Pfizer Inc
|
35,762 | $861,148 | |
| 6 | AMGN |
Amgen Inc
|
1,306 | $472,928 | |
| 7 | NVS |
Novartis AG
|
2,050 | $321,276 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,424 | $312,530 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,263,527 | 17,615 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,148,980 | 17,865 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,880,469 | 17,865 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,436,461 | 17,115 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,321,180 | 16,690 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,480,142 | 16,490 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,727,470 | 17,365 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,070,766 | 18,235 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,257,493 | 18,235 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,406,108 | 18,235 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,987,979 | 18,235 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,877,293 | 18,235 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,047,826 | 17,747 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,891,933 | 17,783 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $1,989,666 | 17,933 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,497,454 | 17,388 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $1,515,518 | 16,623 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,359,814 | 16,573 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,260,574 | 16,448 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $1,180,954 | 15,723 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,154,728 | 14,848 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,144,632 | 14,848 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,171,620 | 14,323 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $88,258 | 1,064 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $938,245 | 12,133 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $1,018,685 | 13,240 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||